biology-technology-1/bmp-sunstone-reports-third-quarter-2009-financial-results-14771-4/;+health+history;+medical+history.html

Breaking Biology Technology:New silicon-germanium nanowires could lead to smaller, more powerful electronic devices 2 New silicon-germanium nanowires could lead to smaller, more powerful electronic devices 3 Sirius Genomics Announces Change in Leadership 2 BioMed Realty Announces Results of Tender Offer for its Exchangeable Notes 2 BioMed Realty Announces Results of Tender Offer for its Exchangeable Notes 3 Olympics 2016, World Cup 2014, But First – Adventus Brasil 2009 2 Olympics 2016, World Cup 2014, But First – Adventus Brasil 2009 3 Olympics 2016, World Cup 2014, But First – Adventus Brasil 2009 4

[0] New silicon-germanium nanowires could lead to smaller, more powerful electronic devices [0] Sirius Genomics Announces Change in Leadership [0] BioMed Realty Announces Results of Tender Offer for its Exchangeable Notes [0] Olympics 2016, World Cup 2014, But First – Adventus Brasil 2009

Breaking Medicine Technology:OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 2 OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 3 OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 4 Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 2 Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 3 Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 4 Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 5 Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 6 Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 7 Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 8 Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 9 Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 10 Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 11 Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 12 Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 13 Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 14 Masimo Receives 2009 Zenith Award at the American Association of Respiratory Care Congress 2 Masimo Receives 2009 Zenith Award at the American Association of Respiratory Care Congress 3 Masimo Receives 2009 Zenith Award at the American Association of Respiratory Care Congress 4 Masimo Receives 2009 Zenith Award at the American Association of Respiratory Care Congress 5 NQF Helps Ensure Health IT Captures Information to Drive Quality Improvement 6214 1 NQF Helps Ensure Health IT Captures Information to Drive Quality Improvement 6214 2 NQF Helps Ensure Health IT Captures Information to Drive Quality Improvement 6214 3 Mithridion Announces Progress With Drugs for Alzheimers Disease and Schizophrenia 6211 1 Mithridion Announces Progress With Drugs for Alzheimers Disease and Schizophrenia 6211 2 Mithridion Announces Progress With Drugs for Alzheimers Disease and Schizophrenia 6211 3 Gene Therapy Brings New Muscle to Monkeys 61251 1

[0] OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months [0] Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 [0] Masimo Receives 2009 Zenith Award at the American Association of Respiratory Care Congress